Kohlberg Kravis Roberts

Kohlberg Kravis Roberts (KKR) is a global investment firm established in 1976, headquartered in New York. It manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate, and credit. Through strategic partnerships, KKR also invests in hedge funds. The firm employs a patient and disciplined approach, focusing on long-term value creation and generating attractive returns for its fund investors across various sectors such as business services, consumer products, energy, financial services, and technology.

Benjamin Adler

Principal

Ankit Aggarwal

Principal, Private Equity and Member of the Private Equity Team and Global Impact Team

Ruchika Agrawal

Principal, KKR India Asset Finance

Barkha Agrawal

Principal, Infrastructure

Taski Ahmed

Principal, KKR Prisma

Salwa Alahdal

Principal, Client and Partner Group

Pamela Alexander

Managing Director and Head of Corporate Citizenship, Public Affairs

Claude Alexandre

Principal, KKR Capstone

Amit Alleck

Principal, Global Impact

Jessica Allen

Principal, Tech Growth

Racim Allouani

Managing Director

Mustapha Angwa

CEO

Anne Arlinghaus

Managing Director

Neil Arora

Partner, Infrastructure

Annabel Arthur

Director and Head of EMEA Corporate Communications

Paul Atefi

Managing Director, Credit and Head of Origination for Credit and Markets in Europe

Jesse Audet

Director

David Aung

Principal, Credit

Nisha Awasthi

Managing Director and Head Of Office

Joe Bae

Co-President and Co-COO

Atul Bahl

Principal, Information Technology

Ana Bakhshyan

Principal, KKR Capstone

Ludo Bammens

Managing Director and Head, EMEA Corporate Affairs

Daniel Bankoske

Principal

Paolo Baorda

Principal

Steven Bayly

Managing Director, Client and Partner Group and Head of the Client and Partner Group in the DACH Region

Michaela Beck

Principal and Member of the Global Macro, Balance Sheet and Risk Team

Jessica Bell

Managing Director, KKR Capital Markets and Member of the KKR Capital Markets Co-investments and Partnerships Team

Elliot Bell

Principal, Tech Growth

Eran Benichou

Managing Director and CFO, Asia-Pacific

Lorenzo Bianchi

Principal, KKR Capstone

David Biener

Principal, Finance

Thomas Birkebaek

Principal, KKR Capstone

Betty Blabey

Principal, Client and Partner Group

Stuart Blieschke

Director, KKR Credit

Dave Blodgett

Managing Director and Global Head of Infrastructure and Technical Operations

Anders Borg

Managing Director, Private Equity

Simon Bouchard

Director, Private Equity

Yacine Boumahrat

Managing Director, Client and Partner Group

Yacine Bounmahrat

Managing Director

Jennifer Box

Partner, KKR Credit, Co-Head of Strategic Investments Group, Member of the Strategic Investments Group Investment Committee and Portfolio Manager

Felix Boyeaux

Director, Infrastructure

Brandon Brahm

Partner, Co-Head of KKR Ascendant, Member of the Americas Private Equity Industrials Team, Member of the Investment Committee and Portfolio Management Committee for the Ascendant Strategy

Ana Brajovic

Managing Director, Private Credit

Giacomo Branchini

Principal, Private Equity

Lauren Braswell

Principal, Public Affairs

Bradley Brown

Managing Director, Private Equity

Robbie Brussell

Principal

Todd Builione

Member, President of KKR Credit

Jim Burns

Partner

Riccardo Busani

Principal, Infrastructure

Cathy Cai

Partner and Head of KKR Capstone for Asia Pacific

Gerald Capria

Principal

Mattia Caprioli

Partner, Co-Head of European Private Equity and Member of KKR's European Private Equity Investment Committee and European Portfolio Management Committee

Francesco Cariati

Director

Nicolo Della Casa

Director of Private Equity

Kate Casey

Director

Gearoid Casey

Managing Director, European Leveraged Credit Funds and Portfolios

Daniel Celeghin

Managing Director and Global COO, Global Wealth Business

Saurav Chakraborti

Director

Glenda Chan

Principal, Private Equity

Matthew Chang

Managing Director

Sasank Chary

Managing Director, Private Equity and Member of the Financial Services Industry Team

Spencer Chavez

Director

Mukul Chawla

Partner, Head of Asia Pacific Growth Equity

Kevin Chen

Principal, Private Equity

Victor Chen

Principal

Alan Cheng

Director

Melissa Chew

Principal, Human Capital

Koki Chigusa

Principal

Esther Cho

Director, Core Infrastructure Investments

Jeannie Cho JD

Director and Member of the Sustainable Investing Team

Kyle Choi

Principal, Infrastructure and Member of the Asia Pacific Infrastructure Team

Alex Chomette

Principal, Infrastructure

Christa Choy

Principal, Private Equity and Member of the Financial Services Industry Team

Lauren Chung

Principal, Health Care Growth

Patrick Clancy

Director

Victoria Clarke

Principal, Private Equity

Iñaki Cobo

Partner, Private Equity and Head of the European Health Care Sector Team and KKR's Regional Operations in Spain

Steve Codispoti

Director, Finance

Benjamin Conner

Managing Director, Energy Real Assets

Hunter Craig

Managing Director, Private Equity and Member of the Health Care Industry Team

Boris Dangubic

Director, Private Equity

Eric Darmawan

Principal, Private Equity

Tara Davies

Partner, Global Head of Core Infrastructure, Member of the Infrastructure Investment Committee and Infrastructure Portfolio Management Committee and Co-Head of European Infrastructure

Anita Davis

Director and Head of Asia Pacific Corporate Communications

Kendra Decious

Director, Finance

Chris Decker

Principal, Infrastructure

Kruti Desai

Associate and Principal

Aaron Dickie

Principal and Member of KKR Credit

Brian Dillard

Partner, Credit and Head of Asia Credit

Hayley Donaldson

Principal, Private Equity and Member of the TMT Industry Team

Brandon Donnenfeld

Managing Director, Client and Partner Group

Till Dorp

Principal, Private Equity and Member of the European Private Equity Team

Christopher Drewsen

Director, Private Equity and Member of the Industrials Industry Team

Ngoc Duong

Principal, Private Equity and Member of the Health Care Industry Team

Harald Duerr

Managing Director and Head of Family Capital, DACH

David Edwards

Principal, Infrastructure

Andrew Egan

Principal

Markus Egloff

Managing Director and Head of Asia Wealth

Susan Eisenberg

Principal, Credit

Julian Elburn

Principal, KKR Credit

Jamison Ely

Director

Mark Ennis

Director

Tom Farmakis

Principal

Clark Feng

Managing Director, Private Equity

Len Fliegel

Director

Marco Fontana

Managing Director

Nancy Ford

Partner, Co-Head of KKR Ascendant, Member of the Americas Private Equity Consumer Team, Investment Committee, Portfolio Management Committee for the Ascendant Strategy and Americas Inclusion and Diversity Council

Mary Fox

Principal, Finance

Charlie Gailliot

Partner, Infrastructure and Global Co-Head of Climate strategy

Terence Gallagher

Managing Director, Finance

Michael Gallagher

Principal, Finance

Reid Gallagher

Principal, Energy Real Assets

Carlos Galvez

Principal, Credit

Charlie Gao

Director, Private Equity

Travers Garvin

Managing Director, Public Affairs and Member of the Global Public Affairs Team

Felix Gernburd

Partner, Private Equity

Julia Giese

Principal, European Infrastructure

Matthew Goh

Director

Lucas Goh

Principal, Asia Pacific Infrastructure

James Gordon

Partner, Energy and Infrastructure

Vikram Govindan

Managing Director, Insurance and Strategic Finance

Alan Grant

Principal, KKR Capstone

Simon Greene

Director, Private Equity and Member of the Financial Services Industry Team

John Grooms

Principal, Private Equity and Member of the TMT Industry Team

Ibrahim Gsibat

Principal

Dong Guang

Principal, Private Equity

Rafael Guillen

Principal, European Infrastructure

Nico Haller

Director

Elizabeth Hammond

Managing Director

Chris Hanlon

Director, KKR Capstone

Paul Harragan

Principal and Global Cybersecurity Lead

Chris Harrington

Partner

Deyllen Harrington

Principal, Private Equity

Christopher Harrington JD

Partner, Private Equity, Member of the Investment Committee and Member of the Portfolio Management Committee for Americas Private Equity

Cathy He

Principal, Private Equity

Erich Heintzen

Director

Jill Henn

Managing Director, Human Capital

Stanley Ho

Managing Director, Client and Partner Group

Sota Horiuchi

Principal, Private Equity

Jeff Van Horn

Managing Director, Credit

Paul Horwood

CFO, European Operations

Changchun Hua Ph.D

Managing Director, Global Macro, Balance Sheet and Risk and Chief Economist for Greater China

Mark Hunt

Director, Capital Management Group

Hadi Husain JD

Managing Director, Global Macro, Balance Sheet and Risk

Jae Hwang

Director, KKR Capital Markets

Nicholas Hyde

Managing Director and Head of Client and Partner Group

Adam Hyland

Director, Operations and Head of Fund Operations and Treasury

Gianmarco Iannello

Principal

Hisao Iijima

Principal, Private Equity

Gary H. Jacobs

Managing Director, Capital Management Group

Andre Jakubowski

Director, Credit

James Jankoski

Director, Credit

Zhen Ji

Managing Director, Private Equity

Sophia Jiang

Principal

Ray Jin

Principal, Private Equity

Alice Joe

Principal

Russell Johnson

Principal, Technology Growth

Philip Joseph

Principal and Member of Energy Real Assets team

Anogie Joseph-Erameh

Director, KKR Capstone and Global Co-Head of Capstone Infrastructure

Miguel Jover

Director, Strategic Investments Group

Javier Justiniano

Director

Sophia Kakarakis

Principal

Masamu Kakinoki

Director, Client and Partner Group

Seunghee Kang

Principal of North American Infrastructure

James Kang

Principal, KKR Credit

David Katz

Managing Director, Global Public Affairs Team, Asia Pacific

Evan Kaufman

Director, Global Impact

Franziska Kayser

Partner and Member of the European Private Equity team

Alexandre Kemlin

Director, KKR Capstone

Devid Kennedy

Director of Private Equity

David Kerko

Director

Kazuyuki Kido

Managing Director

Anna Kilmartin

Principal, Private Equity

Philip Kim

Managing Director

Keith Kim

Partner and Member of the Asia Pacific Infrastructure Team

Thomas Kim

Managing Director and Global Risk Manager, KKR Capstone

Johnny Kim

Director, Private Equity and Member of the Health Care Industry Team

Adam King

Principal

David Kirby

Managing Director, KKR Capital Markets

Daan Knottenbelt

Partner

Daniel Knottenbelt

Partner, Private Equity and Member of the European Private Equity Investment Committee, European Portfolio Management Committee and Asset Based Finance Investment Committee

Jae Ko

Managing Director, Client and Partner Group

Rie Koike

Principal, Client and Partner Group

Audrey Kornkven

Associate

Maxim Kovalchuk

Principal, Hedge Funds

Prashant Kumar

Partner

Ivan Kwong

Principal, Global Impact

Joan Lacagnina

Managing Director, Finance

Emmanuel Lagarrigue

Partner, Infrastructure and Co-Head Global Climate

Kirby Lam

Principal, Technology Growth

Nonie Lame

Managing Director, Human Capital

Amina Lamloum

Director, Private Equity and Member of the European Private Equity Team

Jeremiah Lane

Principal

David Lang

Partner, Co-Head of Australia and New Zealand and Head of the Private Equity team for KKR in Australia and New Zealand

Joshua Lederman

Managing Director, Capital Markets

Craig Lee JD

Partner and Head of Insurance and Strategic Finance

Jennifer Lee

Managing Director, Credit

Mitchell Lee

Managing Director and Member of the KKR Insurance team

Josh Lee

Director, Private Equity

Elissa Leechawengwongs

Principal, Private Equity

Jonathan Levy

Principal

Robert Lewin

Partner

Mark Li

Director

Xiang Li

Managing Director, Private Equity

Yufei Li

Principal

Lu Li

Principal, Asia Pacific Infrastructure

Frances Lim

Managing Director, Global Macro, Balance Sheet and Risk

Lucy Liu

Managing Director, Client and Partner Group

Julien Lo

Principal, Private Equity and Member of the Healthcare and DACH Industry and Regional Teams

Cecilia Lopez

Principal, Private Equity and Member of the Technology, Media and Telecommunications Industry Team

Ming Lu

Partner and Executive Chairman of Asia Pacific

Binghui Lu

Director

David Luboff

Partner and Head of Asia-Pacific Infrastructure and Co-Head of Australia and New Zealand

Hillary Lundgren

Principal and Member of the Investment Control Team

Erin Lyons

Principal, Credit Product Specialist

Blaine MacDougald

Director and Co-head of Credit Research, Credit

Catherine Madigan

Managing Director of KKR Credit and Member of the Investment Committee for the FS / KKR BDC platform and Capital Committee, KKR Debt Capital Markets Business

Nnamdi Maduagwu

Director

Cara Major

Principal, Public Affairs

Rizul Makkar

Principal

Burke Malek

Managing Director and Global Head of Operations

Tomas Maraver

Principal, Capital Markets

Daniel Marcus

Principal, Private Equity and Member of the Health Care Industry Team

Emily Mason

Principal, KKR Prisma

Micaela Mastrogiannis

Principal and Member of the Global Macro, Balance Sheet and Risk T

Kyle Matter

Managing Director of Global Impact, North America and Member of the Global Impact Investment Committee and Portfolio Management Committee

Hannah May

Director and Chief of Staff to Co-CEO, Joe Bae

Sean McCorry

Managing Director, Client and Partner Group and Member of the Credit Strategies Team

Eleanor McEnaney

Principal, Global Impact

Elise McKenna

Principal

Kevin McMahon

Managing Director, Client and Partner Group

Brian McNamara

Principal, Credit

Hilary McNamara

Managing Director, Human Capital

David McNellis

Managing Director, Global Macro, Balance Sheet and Risk

Henry McVey

Partner, Head of Global Macro, Balance Sheet and Risk, Chief Investment Officer of KKR Balance Sheet and Member of the Balance Sheet Committee

Alexandre Meeuwen

Director

James Megibow

Principal

Ken Mehlman

Partner and Global Head of Public Affairs; Co-head KKR Global Impact

Aadhaar Mehra

Principal and Member of the European Infrastructure

Vishva Mehta

Principal, Private Equity

Rahul Mehta

Principal, Hedge Funds

Mahek Mehta

Director, Infrastructure

Christopher Mellia

Managing Director

Samuel Mencoff

Director, Credit and Member of the Asset Based Finance Team

Stavros Mercouris

Managing Director, Private Equity and Member of the European Private Equity Team

Jimmy Miele

Principal

Peter Milinazzo

Principal

Mayank Mishra

Director, Private Equity and Member of the Asia Private Equity Team

Hideaki Miyauchi

Principal

Dan Moore

Managing Director, Information Technology

Dima Mostovoy

Managing Director

George Mueller

Partner

Katherine T. B. de Mul

Managing Director and Global Head of Client Services

Kevin Murphy

Director, Private Equity and Member of the Core Investments and Americas Private Equity Teams

Ryan Murphy

Managing Director, KKR Capital Markets

Narender Nanchary

Principal, Hedge Funds

Nicolas Naranjo

Principal, KKR Capstone

Madhura Narawane

Principal, Asia Pacific Infrastructure

Omar Nazzal

Director, Private Equity and Member of the Technology, Media and Telecommunications Industry Team

William Needham

Managing Director, Credit

Sean Nelson

Managing Director, Client and Partner Group

James Newman

Managing Director, KKR Credit

Monica Ng

Principal

Alberta Ngan

Principal, Private Equity and Member of the Private Equity Team, Southeast Asia

Bernardo Nogueira

Director, European Energy and Infrastructure

Jerome Nomme

Partner, Head of France and Member of Private Equity Investment Committee

Kristopher Novell

Managing Director, Portfolio Construction and Risk and Member of the Asia Tactical Credit Investment Committee

Lesley Nurse

Director, Client and Partner Group

Scott Nuttall

Co-CEO

Kevin O'Neill

Director, KKR Credit

Kieran O'Neill

Principal, KKR Credit

Conor O'Neill

Principal, Credit

Ted Oberwager

Partner, Private Equity and Lead of the Gaming, Entertainment, Media and Sports, Americas Private Equity Platform

Tatsuya Ochi

Principal, Private Equity

Chin Yu Oh

Director

Christian Ollig

Director, Private Equity

Timotheus Osnabrug

Director, Private Equity

Sandra Ozola

Partner and Global Head of Human Capital

James Paquette

Managing Director, Credit

John Park

Director, Private Equity

Chung Ho Park

Director, Private Equity

Kartik Patel

Principal, KKR Prisma

Jeff Peate

Principal, Client and Partner Group

Ben Pederson

Director, Tech Growth

Rupert Pedler

Director, Private Equity and Consumer Industry

Andrew Peisch

Managing Director, Infrastructure

Alessandra Pelliccia

Principal, KKR Capstone

Ross Pereira

Principal

Clayton Perry

Managing Director, Client and Partner Group

David Petraeus

Partner and Chairman of the KKR Global Institute

Giacomo Picco

Managing Director, Credit

Samuel Plotner

Director

Conor Power

Principal, Credit

Douglas Powers

Principal, Infrastructure

Porus Prakash

Principal, Credit

Elizabeth Qian

Director, Private Equity and Member of the Technology, Media and Telecommunications industry team

Zhiling Qiu

Principal, KKR Capstone

Gabriele Questa

Managing Director, KKR Capstone

Pedro Ramos

Director, Global Impact

Anuv Ratan

Director, Private Equity and Member of the Health Care Industry Team

Sarvesh Rathi

Principal, KKR Capstone

Valeria Rebulla

Managing Director and COO, EMEA

Sharath Reddy

Director, Credit

John Reed

Director, Credit

Lauriane Requena

Principal, Tech Growth

Sören Riebeling

Principal, Private Equity and Member of the European Private Equity Team

Jonathan Rin

Principal, Hedge Funds

Janice Cook Roberts

Director, Client and Partner Group

Paul Roberts

Managing Director, KKR Prisma

Paula Roberts

Managing Director - Chief Investment Strategist, Private Wealth Partners

Eileen Roche

Principal

Erika Rodriguez

Principal, Sustainable Investing

Olivia Rogan

Director, Private Equity and Member of the Financial Services Industry Team

Noah Rosenthal

Director, Credit

Matthew Ross

Managing Director, Credit

Patricia Rothacker

Principal, Private Equity

James Rudy

Director, Principal Activities

Ed Ruiz

Principal, Information Technology

Michael Ryan

Managing Director

Jean-Pierre Saad

Partner, Private Equity, Member of the European Private Equity Platform and Member of the European Private Equity Investment Committee, Portfolio Management Committee and Next Generation Technology Growth Investment Committee

Jean -Pierre Saad

Director, Private Equity

Kaveh Samie

Managing Director, Client and Partner Group

Elizabeth Saracco

Principal, KKR Prisma

Richard Sarnoff

Managing Director

Kugan Sathiyanandarajah

Partner and Head of Health Care Strategic Growth Business in Europe and Member of the Health Care Industry Team

Ali Satvat

Partner, Head of Health Care Strategic Growth

Jeffrey Schachter

Managing Director

Philipp Schaelli

Director, Private Equity and Member of the Technology, Media and Telecommunications Industry Team

Lucian Schönefelder

Partner

Elizabeth Seeger

Managing Director, Sustainable Investing

Vance Serchuk

Managing Director

Cristina Serna

Principal, Private Equity and Member of the European Private Equity Team

Grayson Sessa

Principal, Private Equity and Member of the Financial Services and Technology Industry Team

Jonathan Sharkey

Principal

Peggy Shaughnessy

Managing Director

Blake Shorthouse

Managing Director, Client and Partner Group

Alberto Signori

Partner, Infrastructure

Martelle Simpson

Associate, Client and Partner Group

Chris Singh

Principal, Credit

Sjoerd Smaal

Principal

Michael Small

Partner, Credit and Markets Business, Member of the Global Private Credit Investment Committee, European Direct Lending Investment Committee, Asia Credit Investment Committee and KKR Credit Portfolio Management Committee

Duncan Smith

Principal, Credit

Vivan Som

Principal, Private Equity and Member of the Technology Industry Team

Alissa Song

Principal, Private Equity and Member of the Industrials Industry Team

Stefan Stefanov

Principal, Credit

George Stephan

Director, Client and Partner Group and COO of KKR's Americas Private Wealth Partners Business

David Stern

Managing Director, Chief Information Security Officer

Evelyn Stevens

Director, KKR Credit

Eric Stout

Director, Private Equity and Member of the Industrials Industry Team

Chris Sun

Partner, Private Equity

Karan Swani

Director, Private Equity

Pawel Swierczynski

Principal

Marta Szczerba

Director

Shota Takamoto

Associate

Yong Yi Tan

Director, Private Equity

Weiyu Tan

Managing Director

Akshay Tanna

Partner and Head of India Private Equity

Nate Taylor

Co-Head of Americas Private Equity

Henock Teklu

Principal, KKR Credit

Paige Thacher

Principal

Keshav Thakkar

Principal

Cade Thompson

Partner, Capital Markets

Miles Radcliffe-Trenner

Principal, Public Affairs and Member of the Global Public Affairs Team

Carrie Tse

Principal, Asia Pacific Human Capital

Anisha Vachani

Principal, KKR Capstone

Cecilio Velasco

Managing Director, Infrastructure

Jaime Villa

Principal, Global Macro and Asset Allocation

Cav Walters

Director, Infrastructure

Steven Wang

Principal, Private Equity

Alexander Ward

Principal, Private Equity

Douglas Watt

Managing Director, Client and Partner Group

Jean-Marie Wecker

Principal

Joshua T. Weisenbeck

Partner

Claire Wellby

Director, Private Equity

Dave Welsh JD

Partner and Head of Technology Growth Equity

Merrin White

Director and Chief of Staff to Co-CEO, Scott Nuttall

Nicole Wilson

Director

Mya Win

Managing Director and Head of Financial Planning and Analysis, Finance

Monika Wincel

Principal, KKR Capstone

Colin Winrow

Principal

Alisa A. Wood

Partner, Private Equity

Edwin Xiao

Principal, Private Equity

Angela Yang

Principal

Annie Yangeksakul

Principal, Hedge Funds

Nathaniel Yap

Director, KKR Asset Management and Head of Credit Research

Irene Yeung

Principal, Client and Partner Group

Joshua Yu

Principal, Private Equity

Adal Zamudio

Managing Director, KKR Capstone

Yang Zhang

Director, KKR Capstone

Sarah Zhang

Director, Client and Partner Group

Hubert Zhang

Director, Client and Partner Group

Karen Zhang

Director, Private Equity and Head, Technology Investing, China

Grace Zhao

Principal

Anna Zhu

Principal

Aidan Corcoran Ph.D

Managing Director and Co - Head Global Macro, Balance Sheet and Risk

Jackson Hart

Principal

Past deals in Medical Devices

Karo Healthcare

Acquisition in 2025
Karo Pharma is a pharmaceutical company. The company develops and markets products for pharmacies and directly to the healthcare sector. The product portfolio includes over-the-counter and prescription pharmaceuticals as well as medical devices.

HealthCare Global Enterprises

Acquisition in 2025
HealthCare Global Enterprises Limited is a prominent healthcare provider in India, specializing in cancer diagnosis and treatment. The company offers a comprehensive range of services including radiation therapy, medical oncology, and surgical interventions. It operates under the HCG brand and manages several multi-specialty hospitals that provide additional medical services such as cardiology, neurology, orthopedics, gastroenterology, urology, and critical care. In addition to cancer care, HealthCare Global Enterprises also runs fertility clinics under the Milann brand, offering services in reproductive medicine, assisted reproduction, and fertility preservation. As of March 2020, the company operated 22 cancer centers across India and one center in Africa, including a center of excellence in Bengaluru. Their facilities also provide medical diagnostic services, incorporating advanced scientific testing and consultancy for the pharmaceutical and medical sectors. Founded in 1989 and headquartered in Bengaluru, India, HealthCare Global Enterprises is committed to delivering specialized healthcare solutions.

HealthCare Global

Acquisition in 2025
HealthCare Global Enterprises Ltd, headquartered in Bangalore, India, is recognized as a leading specialist in cancer care, operating a dedicated network of 20 centers. The organization provides comprehensive and quality cancer treatment, serving approximately 35,000 new patients annually. With a focus on advanced, complicated, and recurrent cancers, HealthCare Global has established a strong reputation both nationally and internationally. The organization's commitment to excellence in oncology was acknowledged with accolades for being a leader in the field in consecutive years, specifically during 2011 and 2012, when it received recognition in the Indian Health Care Awards.

Henry Schein

Post in 2025
Henry Schein is a leading provider of healthcare products and services, primarily catering to office-based dental, medical, and animal health practitioners. The company operates through two main segments: healthcare distribution and technology & value-added services. In its healthcare distribution segment, Henry Schein combines global dental and medical businesses to distribute a wide range of consumable products, small equipment, laboratory supplies, and vitamins. The technology and value-added services segment focuses on offering practice management software and other technological solutions that enhance operational efficiency for healthcare professionals. With a strong emphasis on leveraging a network of people and technology, Henry Schein aims to support practitioners in delivering high-quality care.

smaXtec

Venture Round in 2025
smaXtec provides an advanced health monitoring system for dairy farmers, utilizing bolus technology to continuously measure internal body temperature, rumination, and activity in cows. This innovative approach helps farmers achieve stable high milk yields while reducing antibiotic use and enhancing animal welfare. By offering a 24/7 monitoring solution, smaXtec increases the efficiency of operations on professional dairy farms, contributing to the overall stability and profitability of the dairy industry. The company's technology not only supports the economic aspects of dairy farming but also promotes sustainability in agricultural practices worldwide.

Cortex

Private Equity Round in 2023
Cortex is creating an innovative, totally integrated, all-encompassing platform for assessing and treating AFib with precision, simplicity, and speed. The company has formed a proficient team comprising highly skilled and experienced engineers and clinical experts dedicated to introducing this innovative suite of technologies to the market.

Precipart

Private Equity Round in 2023
Precipart is a medical device company that offers motion control systems, ceramic injection molding, and micro manufacturing.

Bausch Health Companies

Post in 2023
Bausch Health Companies Inc. is a global specialty pharmaceutical, consumer health, and medical device company headquartered in Laval, Canada. It develops, manufactures, and markets a diverse range of products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four key segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment focuses on vision care, surgical, consumer, and ophthalmology products. The Salix segment is dedicated to gastroenterology products, while Ortho Dermatologics specializes in dermatological solutions. The Diversified Products segment includes pharmaceutical offerings in neurology and other therapeutic classes, alongside generic and dental products. Bausch Health is recognized as a market leader in consumer vision care in various regions, including India and China, and ranks among the top vision care companies in the United States.

Industrial Physics

Acquisition in 2023
Industrial Physics is a manufacturer and distributor of test, measurement, and inspection equipment, catering to diverse industries such as food and beverage, metal cans, flexible packaging, paper and plastics, paint and coatings, medical devices, materials testing, and consumer electronics. The company specializes in providing tools that test, measure, inspect, and validate the quality of products and samples, ensuring compliance with specifications and safety standards for end users. By focusing on these critical functions, Industrial Physics plays a vital role in maintaining product integrity across various sectors.

Bushu Pharma

Acquisition in 2022
Bushu Pharma is a pharmaceutical products manufacturing firm. Their products include solid formulation, injection, active drug, packaging, investigational new drug, analysis, medical equipment, and veterinary drugs.

Clinisupplies

Acquisition in 2022
Clinisupplies is a manufacturer and supplier of medical supplies focused on managing both acute and chronic conditions. The company provides a range of products, including intermittent catheters, tubular support bandages, urinary sheaths, catheter valves, surgical tape, triangular bandages, and drainage bags. Clinisupplies also offers Clinidirect home delivery and clinical nursing services, in collaboration with NHS professionals. Their nursing team delivers drop-in clinics and home visits, offering advice and guidance on products, as well as clinical education and training. This comprehensive approach ensures effective management of community spending and enhances patient care through accessible medical technology.

Bettcher Industries

Acquisition in 2021
Bettcher Industries is an ISO 9001-certified manufacturing company established in 1944, known for its innovative equipment designed for the food processing, foodservice, industrial, and medical sectors. With over seventy years of experience, Bettcher Industries develops a wide range of products, including trimmers, weighing systems, food safety equipment, batter breading machines, pneumatic shears, electric gyro knives, and sharpening tools. These products enable food processing industries to efficiently transform raw materials into marketable food items while also providing solutions for industrial and medical applications that alleviate the discomfort associated with manual systems. The company serves a diverse global customer base, emphasizing quality and innovation in its manufacturing processes.

Sapphiros

Series A in 2021
Sapphiros is a private equity growth and expansion firm founded in 2021 and based in Massachusetts. The company specializes in investing in growth-stage diagnostic companies, emphasizing innovative and patient-centric technologies. Its portfolio includes a diverse range of capabilities, such as advanced sample collection methods, next-generation diagnostics, computational biology, and printed electronics. By focusing on these areas, Sapphiros aims to enhance the global accessibility of essential diagnostic results for consumers, thereby contributing to advancements in healthcare and diagnostic-related innovations.

EchoNous

Venture Round in 2021
EchoNous, Inc. is a medical device company based in Redmond, Washington, focused on developing advanced ultrasound systems that enhance bladder and kidney care. Incorporated in 2015, EchoNous specializes in point-of-care ultrasound (POCUS) applications, utilizing artificial intelligence and machine learning to improve diagnostic accuracy and efficiency. Its product lineup includes KOSMOS for cardiothoracic assessments, Vein for ultrasound-guided peripheral IV placement, and Uscan, an AI-driven tool for bladder assessment. The company aims to address common healthcare challenges by providing miniaturized ultrasound devices that streamline clinical workflows and enhance patient care, ultimately saving time and reducing costs for healthcare providers.

PHC Holdings

Private Equity Round in 2021
PHC Holdings Corp is a global corporation dedicated to the development, manufacture, and sale of healthcare devices and services. Leveraging its expertise in consumer electronics and appliances, the company focuses on creating innovative healthcare and research technologies. By integrating ideas and advancements from its extensive network of industrial and consumer products, PHC Holdings aims to address significant global challenges in health and wellness. The company is recognized for delivering a comprehensive range of biomedical products that enhance healthcare delivery and improve patient outcomes.

Paige

Series C in 2021
Paige, founded in 2017 by Thomas Fuchs and colleagues from Memorial Sloan Kettering Cancer Center, specializes in computational pathology products that enhance cancer diagnostics. The company has developed a platform utilizing advanced deep learning algorithms to improve diagnostic stratification and cancer detection, particularly for breast and prostate cancers. This innovative technology aims to empower patients and their care teams to make informed treatment decisions by providing pathologists with critical insights for more accurate diagnoses. Paige's user-friendly platform minimizes the burden on IT resources while ensuring patient safety and data privacy. As a pioneer in the field, Paige has achieved FDA breakthrough designation for its computational pathology products, positioning itself at the forefront of transforming pathology workflows and increasing diagnostic confidence.

Clinisupplies

Acquisition in 2020
Clinisupplies is a manufacturer and supplier of medical supplies focused on managing both acute and chronic conditions. The company provides a range of products, including intermittent catheters, tubular support bandages, urinary sheaths, catheter valves, surgical tape, triangular bandages, and drainage bags. Clinisupplies also offers Clinidirect home delivery and clinical nursing services, in collaboration with NHS professionals. Their nursing team delivers drop-in clinics and home visits, offering advice and guidance on products, as well as clinical education and training. This comprehensive approach ensures effective management of community spending and enhances patient care through accessible medical technology.

J B Chemical & Pharmaceuticals

Acquisition in 2020
Established in 1976, J.B.Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest growing pharmaceutical companies. An integrated, research-oriented, public listed organisation with a focus on supplying affordable, quality products both in India and International markets, JBCPL is trusted by healthcare professionals globally. Today, JBCPL exports to over 30 countries across the world and earns more than half its revenue from its international business. JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules. JBCPL has its headquarters in India’s financial capital, Mumbai. With a domestic sales force of 1,000 people, 17 internationally approved state of the art manufacturing units, a Research and Development Centre, and subsidiaries abroad, the organisation is continually enhancing value for its shareholders. In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL.

Minnesota Rubber & Plastics

Acquisition in 2018
Minnesota Rubber and Plastics is a developer and manufacturer specializing in custom-molded elastomeric and thermoplastic components and assemblies. The company serves various end markets, including medical, water, and industrial sectors, by offering a range of solutions such as custom molded rubber, liquid silicone rubber (LSR) injection molding, over-molded solutions, inflatable seals, and gaskets. In addition to manufacturing, Minnesota Rubber and Plastics provides comprehensive product development services that encompass engineering design, prototyping, and final production. This integrated approach enhances innovation and accelerates product development, allowing clients to benefit from their expertise in materials science and engineering.

Hetian Group

Acquisition in 2018
Anhui Hetian Medical Investment Management Group Co., Ltd. is a professional hospital management company based in Hefei, China. The organization specializes in investing in, holding, and merging healthcare entities, with a focus on integrated health care service providers. Hetian currently operates seven award-winning hospitals and healthcare centers, primarily serving underserved cities in China. The company's vision is to enhance access to quality health care services by establishing a network of primary medical care providers, all supported by modern healthcare management practices.

Ajax Health

Series B in 2018
Ajax Health, established in 2017, is a venture capital firm headquartered in Menlo Park, California, with an additional office in New York City. The company specializes in investing in innovative medical device companies, digital health, healthcare services, and biotechnology across all stages of a company's lifecycle. Ajax Health seeks to accelerate medical innovation by providing capital and strategic capabilities to address major healthcare issues.

Hyperion Materials & Technologies

Acquisition in 2017
Hyperion Materials & Technologies is a global manufacturer specializing in innovative solutions using cemented carbide, diamond, and cubic boron nitride. The company provides a comprehensive range of wear-resistant tools and components designed for various industries, including aerospace, automotive, electronics, and medical sectors. By developing and manufacturing tungsten carbide powders and other advanced materials, Hyperion enables its customers to enhance their business performance through the use of effective and durable cutting and drilling equipment. The company's focus on hard and super-hard materials positions it as a key player in meeting the demanding needs of its clients across multiple manufacturing applications.

EchoNous

Series B in 2017
EchoNous, Inc. is a medical device company based in Redmond, Washington, focused on developing advanced ultrasound systems that enhance bladder and kidney care. Incorporated in 2015, EchoNous specializes in point-of-care ultrasound (POCUS) applications, utilizing artificial intelligence and machine learning to improve diagnostic accuracy and efficiency. Its product lineup includes KOSMOS for cardiothoracic assessments, Vein for ultrasound-guided peripheral IV placement, and Uscan, an AI-driven tool for bladder assessment. The company aims to address common healthcare challenges by providing miniaturized ultrasound devices that streamline clinical workflows and enhance patient care, ultimately saving time and reducing costs for healthcare providers.

Signostics

Venture Round in 2017
Signostics Limited is a medical technology company based in Clovelly Park, Australia, that specializes in the development and manufacture of portable point-of-care devices for both medical and veterinary markets. The company's flagship products include the SignosRT Bladder Scanner, which utilizes ultrasound technology to detect the bladder and calculate its volume, and the SignosRT Handheld Ultrasound, designed to assist clinicians in their examinations. These devices cater to a variety of applications, including hospital medicine, family practice, remote healthcare, and physical therapy. Established in 2005, Signostics has expanded its reach internationally, with regulatory approvals for its products in the United States, Europe, and Australia. The company also maintains offices in Palo Alto, California, and continues to focus on delivering innovative and accessible medical solutions through a network of global distributors.

Laser Clinics Australia

Acquisition in 2017
Laser Clinics Australia Pty Limited, founded in 2007 and based in Sydney, is a leading provider of non-surgical cosmetic treatment services in Australia. The company operates over 80 clinics across the country, offering a range of services that include laser hair removal, cosmetic injections, and various skin treatments. Since opening its first clinic in 2008, Laser Clinics Australia has established a strong presence in the cosmetic clinic market by focusing on affordability, accessibility, and reliability, thereby attracting a large and loyal customer base. The business continues to expand, aiming to meet the growing demand for cosmetic treatments nationwide.

Covenant Physician Partners

Acquisition in 2017
Covenant Physician Partners is a privately-held company that owns and operates ambulatory surgery centers, focusing on providing high-quality surgical care. It specializes in minimally invasive and robotic technologies for procedures related to colorectal cancer screening, polyp removal, and digestive tract surgery. In addition to surgical services, Covenant manages anatomic pathology laboratories and physician practices, offering essential back-office functions such as human resources, billing, contract negotiations, and accounting. This comprehensive support allows healthcare professionals to concentrate on patient care while ensuring efficient operational management within their practices.

Ebb Therapeutics

Series B in 2017
Ebb Therapeutics, Inc. is a company specializing in the development of a regional cerebral thermal therapy (RCTT) device aimed at addressing insomnia and sleep disorders. It offers the Ebb Insomnia Therapy, which is a drug-free solution designed to help individuals improve their sleep quality. Founded in 2008 and originally known as Cereve, Inc., the company is headquartered in Pittsburgh, Pennsylvania. Ebb Therapeutics focuses on innovative therapeutic approaches to enhance sleep health without the reliance on pharmaceuticals.

Ajax Health

Series A in 2017
Ajax Health, established in 2017, is a venture capital firm headquartered in Menlo Park, California, with an additional office in New York City. The company specializes in investing in innovative medical device companies, digital health, healthcare services, and biotechnology across all stages of a company's lifecycle. Ajax Health seeks to accelerate medical innovation by providing capital and strategic capabilities to address major healthcare issues.

AcuFocus

Private Equity Round in 2016
AcuFocus, Inc. is an ophthalmic medical device company based in Irvine, California, specializing in small aperture technologies aimed at enhancing near vision. The company offers the KAMRA inlay, designed to restore near vision for presbyopic patients while preserving distance vision. Additionally, AcuFocus develops the IC-8 IOL, a small aperture lens that facilitates a range of vision for patients with cataracts. The AcuTarget HD is another key product, serving as a diagnostic and surgical planning instrument for various vision correction procedures, including LASIK and cataract surgeries. AcuFocus markets its products through distribution partners across the Americas, Asia-Pacific, Europe, and the Middle East, addressing the needs of both physicians and patients in the vision care sector. Founded in 2001, AcuFocus continues to focus on innovative solutions for vision-related challenges.

Spirox

Series C in 2016
Spirox, Inc., based in Menlo Park, California, is a medical device company focused on improving the quality of life for patients with nasal obstruction, particularly those suffering from nasal valve collapse (NVC). Formerly known as Nasoform, Spirox has developed the LATERA absorbable nasal implant, which offers a minimally invasive treatment option for this common yet often undertreated condition. The implant addresses weakened lateral wall cartilage, a significant contributor to nasal airway obstruction. Founded in 2011, Spirox aims to complete product development, secure marketing authorization in the United States, and initiate commercialization efforts to make their innovative solution available to patients. As of July 2017, Spirox operates as a subsidiary of Entellus Medical, Inc.

Cohera Medical

Venture Round in 2015
Cohera Medical, Inc. is a medical device company specializing in the development of surgical adhesives and sealants for various surgical procedures. Founded in 2003 and based in Raleigh, North Carolina, the company offers innovative products such as TissuGlu, a biocompatible surgical adhesive designed for approximating tissue planes in abdominoplasty and other large flap surgeries, and Sylys, a synthetic surgical sealant aimed at reducing anastomotic leakage in gastrointestinal surgeries. TissuGlu is approved for use in the United States and the European Union, while Sylys has received CE Mark approval in Europe for specific applications. Cohera Medical's product line is grounded in a unique chemical design that promotes tissue healing and minimizes fluid accumulation, positioning the company to address various surgical needs across specialties, including plastic, general, and orthopedic surgery. The company continues to expand its portfolio with additional products in development, focusing on surgical mesh adhesives, hemostatic foams, and bone adhesives.

EchoNous

Series A in 2015
EchoNous, Inc. is a medical device company based in Redmond, Washington, focused on developing advanced ultrasound systems that enhance bladder and kidney care. Incorporated in 2015, EchoNous specializes in point-of-care ultrasound (POCUS) applications, utilizing artificial intelligence and machine learning to improve diagnostic accuracy and efficiency. Its product lineup includes KOSMOS for cardiothoracic assessments, Vein for ultrasound-guided peripheral IV placement, and Uscan, an AI-driven tool for bladder assessment. The company aims to address common healthcare challenges by providing miniaturized ultrasound devices that streamline clinical workflows and enhance patient care, ultimately saving time and reducing costs for healthcare providers.

PHC Holdings

Funding Round in 2014
PHC Holdings Corp is a global corporation dedicated to the development, manufacture, and sale of healthcare devices and services. Leveraging its expertise in consumer electronics and appliances, the company focuses on creating innovative healthcare and research technologies. By integrating ideas and advancements from its extensive network of industrial and consumer products, PHC Holdings aims to address significant global challenges in health and wellness. The company is recognized for delivering a comprehensive range of biomedical products that enhance healthcare delivery and improve patient outcomes.

Gland Pharma

Private Equity Round in 2013
Gland Pharma Limited, founded in 1978 and based in Hyderabad, India, specializes in the development, manufacturing, and marketing of injectable-focused generic liquid parenteral products. The company offers a broad range of injectables, including vials, ampoules, pre-filled syringes, and lyophilized products, with key molecules such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections. Gland Pharma's product portfolio spans various therapeutic categories, including anti-infectives, anesthetics, anti-coagulants, oncology, and more. The company is recognized for its pioneering work in Heparin technology in India and is a leader in the Glycosaminoglycans (GAGs) segment. Gland Pharma primarily serves regulated markets, generating a significant portion of its revenue from the United States, Canada, Europe, and Australia. Additionally, the company provides contract development and manufacturing services to global partners, reinforcing its commitment to quality and innovation in the injectable pharmaceutical sector.

Apollo Hospitals

Post in 2013
Apollo Hospitals is a leading provider of private healthcare in India and the first corporate hospital in the country. Initially established as a 150-bed facility, it has expanded to operate 9,200 beds across 64 hospitals, becoming the foremost integrated healthcare provider in Asia. The organization's services span primary, secondary, and tertiary care, with specialized hospitals addressing complex medical fields such as cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. In addition to hospital services, Apollo Hospitals offers a comprehensive range of healthcare solutions, including primary care and diagnostics clinics, telemedicine units, consulting, health insurance, education and training, and research. The Apollo Group has significantly impacted the healthcare landscape, having served over 45 million patients from 121 countries.

Accellent

Acquisition in 2005
Accellent provide manufacturing services to the medical device industry in the cardiology, endoscopy and orthopaedic markets. Accellent has broad capabilities in precision component fabrication, finished device assembly, engineering support services and complete supply chain management. These capabilities enhance customers’ speed to market and return on investment by allowing companies to refocus internal resources more efficiently.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.